Urinary Incontinence — Overview
Urinary incontinence (UI) is the involuntary loss of urine. It affects approximately 25–45% of women and 11–34% of men globally and is substantially under-reported, particularly in GCC communities due to cultural stigma.
Definition (ICS)
Any complaint of involuntary loss of urine. Classification is based on symptoms, urodynamic findings, and underlying mechanism.
Prevalence
- Women: 25–45% lifetime prevalence
- Post-partum women: up to 33%
- Post-menopausal women: increased due to oestrogen deficiency
- Men post-prostatectomy: up to 40%
- GCC: likely under-estimated due to under-reporting
Stress Urinary Incontinence (SUI)
Mechanism
Involuntary leakage on exertion, effort, sneezing, or coughing. Caused by urethral sphincter weakness or pelvic floor dysfunction — intra-abdominal pressure exceeds urethral closing pressure.
Risk Factors
- Vaginal childbirth (especially instrumental)
- Post-menopause (oestrogen deficiency)
- Obesity (BMI >30)
- Chronic cough / heavy lifting
- Post-radical prostatectomy (men)
- Connective tissue disorders
No involuntary detrusor contraction. Bladder diary shows leakage coinciding with activity, no urgency.
Urgency Urinary Incontinence (UUI)
Mechanism
Involuntary leakage accompanied or immediately preceded by a strong sensation of urgency. Caused by detrusor overactivity (involuntary detrusor contractions) — also termed Overactive Bladder (OAB wet).
Features
- Urgency (compelling desire to void, difficult to defer)
- Frequency (>8 voids/24h)
- Nocturia (≥2 voids/night)
- Can be neurogenic (MS, stroke, spinal cord injury) or idiopathic
- OAB dry = urgency without leakage
Mixed Urinary Incontinence
Combination of both stress and urgency UI symptoms. Most common form in women. Treatment targets the predominant symptom first.
Always address the most bothersome component first. Re-assess after treating the predominant symptom.
Overflow Urinary Incontinence
Mechanism
Incomplete bladder emptying leads to overdistension and continuous or intermittent dribbling overflow.
Common Causes
- Benign prostatic hyperplasia (BPH) — most common in men
- Neurogenic bladder (diabetes, spinal cord injury, MS)
- Urethral stricture
- Anticholinergic / opioid medications
- Post-surgical (pelvic surgery, radical prostatectomy)
Post-void residual (PVR) >300mL is diagnostic. Bladder scanner essential. Do NOT initiate bladder training without ruling out overflow.
Functional Urinary Incontinence
Normal or near-normal bladder function but the individual is unable to reach or use the toilet in time due to external factors.
- Mobility impairment (arthritis, post-hip fracture)
- Cognitive impairment / dementia
- Environmental barriers (unfamiliar toilets, restraints)
- Sedating medications
- Depression / reduced motivation
Management focuses on prompted voiding, scheduled toileting, environmental modification, and appropriate containment products.
Continuous Leakage — Fistula
Constant, unremitting urinary leakage suggesting an abnormal connection (fistula) between the urinary tract and another structure.
- Vesico-vaginal fistula (VVF): most common — obstetric (obstructed labour) or post-radiotherapy/gynaecological surgery
- Obstetric fistula: high prevalence in developing regions; some GCC expat populations at risk
- Ureterovaginal fistula: post-hysterectomy
- Cystoscopy, IVU, dye test confirm diagnosis
- Treatment: surgical repair (Martius flap); extended catheterisation for small VVF
Continence Assessment
3-Day Bladder Diary
- Time and volume of each void
- Fluid intake (type and volume)
- Urgency episodes (0–3 scale)
- Leakage episodes with severity
- Activity during leakage
- Pad use
Minimum 3 days for valid data. Calculate: functional bladder capacity, voiding frequency, 24h urine output.
ICIQ-UI SF Questionnaire
- International Consultation on Incontinence Questionnaire — Short Form
- 3 scored questions + 1 diagnostic question
- Score 0–21 (higher = more severe impact)
- Validated in multiple languages including Arabic
- Useful for screening and monitoring treatment response
Post-Void Residual (PVR)
- Measured by bladder ultrasound scanner
- Within 10–15 minutes of voiding
- <100mL = normal
- 100–299mL = clinically significant — recheck
- >300mL = urinary retention / overflow
- Essential before bladder training or anticholinergics
Urinalysis — Always Exclude UTI First
- Dipstick: nitrites + leucocytes = likely UTI
- MSU (midstream urine) for C&S if dipstick positive
- Treat UTI before initiating continence treatment
- Haematuria without infection → urgent urology referral
- Glycosuria → investigate for diabetes (polyuria)
Do NOT diagnose OAB or initiate anticholinergic therapy without excluding UTI. UTI can mimic all features of OAB. Always obtain MSU if dipstick positive.
GCC-Specific Considerations
Under-Reporting & Cultural Barriers
- Incontinence perceived as shameful/embarrassing — rarely volunteered
- Screening questions should be routine in all women's health consultations
- Male patients may refuse assessment by female nurses — assign same-gender where possible
- Arabic-language validated tools (ICIQ-Arabic) available
- Family members often present during consultation — impacts disclosure
Limited Specialist Services
- Urogynaecology subspecialty developing in GCC region
- Specialist continence nurses increasingly recognised role
- Urodynamics availability variable between facilities
- Referral pathways: DHA Dubai, MOH KSA, HAAD Abu Dhabi
- Obstetric fistula: relevant in some expat (South Asian, African) populations
First-line principle: Conservative management should be offered to ALL patients with UI before pharmacological or surgical intervention. Minimum 3-month trial of PFMT before assessing response.
Conservative (First-Line) Management
Bladder Training
- Urgency suppression techniques (distraction, perineal pressure, deep breathing)
- Gradually extend voiding interval by 15–30 min per week
- Target: 3–4 hourly voiding pattern
- Takes 6–12 weeks — patient education on persistence
- First-line for urgency UI and OAB
Pelvic Floor Muscle Training (PFMT)
- Kegel exercises — correct identification critical
- Fast and slow fibre contractions
- Minimum: 3 sets × 8–12 contractions daily
- Hold time: 6–8 seconds, build to 10 sec
- Assess response at 3 months minimum
- Supervised PFMT superior to unsupervised
- First-line for SUI and mixed UI
Fluid & Lifestyle Management
- Adequate hydration: 1.5–2L/day (concentrated urine irritates bladder)
- Reduce bladder irritants: caffeine, fizzy drinks, alcohol, citrus, spicy foods
- Weight reduction: 5–10% body weight reduces UI episodes by ~50%
- Smoking cessation (chronic cough worsens SUI)
- Constipation management (straining worsens pelvic floor)
- Evening fluid restriction for nocturia
Pharmacological Management — OAB / Urgency UI
| Drug Class | Examples | Mechanism | Key Side Effects | Notes |
|---|---|---|---|---|
| Anticholinergic | Oxybutynin (oral/patch/gel) | M3 muscarinic receptor antagonist → reduces detrusor contractions | Dry mouth, constipation, blurred vision, cognitive impairment, tachycardia, urinary retention | AVOID in elderly — cognitive impairment risk (BEERS criteria). Non-oral routes have fewer CNS effects. |
| Anticholinergic | Tolterodine (IR/ER) | M2/M3 receptor antagonist | Dry mouth (less than oxybutynin), constipation | ER formulation better tolerated. Avoid in glaucoma, urinary retention. |
| Anticholinergic | Solifenacin, Darifenacin | M3 selective — more bladder-selective | Dry mouth, constipation (less CNS effects than oxybutynin) | Darifenacin: M3 selective → less cognitive impact. Preferred in older adults if anticholinergic needed. |
| Beta-3 Agonist | Mirabegron | Beta-3 adrenoceptor agonist → bladder relaxation | Hypertension, tachycardia, nasopharyngitis, UTI | Fewer anticholinergic SE. Monitor BP. Contraindicated in uncontrolled hypertension. Preferred in elderly OAB. |
| Beta-3 Agonist | Vibegron | Beta-3 agonist (more selective) | Headache, nasopharyngitis, UTI | Fewer drug interactions than mirabegron. No significant BP effect. |
Clinical reminder: All anticholinergics contraindicated in: acute urinary retention, uncontrolled narrow-angle glaucoma, myasthenia gravis. Always check PVR before starting — overflow UI must be excluded.
Third-Line OAB Interventions
Botulinum Toxin A (OnabotulinumtoxinA)
- Intradetrusor injection (100 units for OAB idiopathic, 200 units neurogenic)
- Performed cystoscopically as day procedure
- Effect lasts 6–9 months → repeat injections
- Risk of urinary retention (10–15%) — patient must be willing/able to self-catheterise
- Used when 2 pharmacological agents have failed
Sacral Neuromodulation (SNS)
- Electrode placed adjacent to S3 sacral nerve root
- Modulates neural pathways controlling bladder
- Indications: refractory OAB, urgency UI, non-obstructive urinary retention
- Test phase (percutaneous nerve evaluation) before permanent implant
- Interstim / Axonics devices
Percutaneous Tibial Nerve Stimulation (PTNS)
- Weekly outpatient sessions (12 weeks), needle at ankle
- Less invasive, no implant required
- Office-based, good for patients refusing surgery
Stress UI — Specific Treatments
Pharmacological
- Duloxetine (SNRI): inhibits serotonin/noradrenaline reuptake → increased pudendal nerve activity → increased urethral sphincter tone. SE: nausea (dose-related, improves over time), headache. Second-line for moderate-severe SUI in women.
- Topical oestrogen (vaginal): improves urethral mucosal coaptation in post-menopausal women. Local application only.
Surgical — Informed Consent Essential
- TVT (Tension-free Vaginal Tape) / TOT (Trans-Obturator Tape): mid-urethral mesh sling — gold standard surgical treatment for SUI
- Mesh controversy: MHRA/FDA alerts — discuss risks (erosion, chronic pain, mesh exposure) vs benefits. Informed consent documentation mandatory.
- Colposuspension (Burch): retropubic, laparoscopic or open — avoids mesh
- Bulking agents: periurethral injections (Bulkamid, Macroplastique) — day procedure, less durable
- Artificial urinary sphincter: men post-prostatectomy
PFMT must be attempted for minimum 3 months before surgery is considered. Ensure correct muscle identification — up to 30% of women squeeze wrong muscles initially.
PFMT — Teaching Correctly (Nursing Role)
Correct Muscle Identification
1
Verbal instruction: "Imagine stopping the flow of urine and passing wind at the same time — squeeze and lift inward"
2
Digital examination: nurse/physiotherapist performs vaginal or rectal palpation to confirm correct contraction (with consent)
3
Biofeedback: surface EMG or perineometer confirms correct recruitment — visual feedback improves compliance
4
Warn against Valsalva: bearing down instead of lifting UP worsens pelvic floor descent — observe for breath holding, abdominal bracing
Exercise Prescription
- Slow fibres: hold 6–10 sec, relax 10 sec — builds endurance
- Fast fibres: quick flicks (1 sec on/off) × 10 — urgency suppression
- 3 sets/day minimum (morning, afternoon, evening)
- Any position (lying, sitting, standing) — progress to functional positions
- Knack manoeuvre: contract BEFORE cough/sneeze — prevents leakage
- Reassess at 3 months — if no response, consider referral for supervised physiotherapy
Persistence is key. Improvement is often gradual. At 3 months, 60–70% of women with SUI show significant improvement with properly supervised PFMT.
Indications for Urinary Catheterisation
Accepted Indications
- Acute urinary retention (AUR) — priority indication
- Monitoring accurate hourly urine output (critical care, major surgery, haemodynamic instability)
- Perioperative use (specific procedures)
- Urological procedures (TURP, cystoscopy)
- Neurogenic bladder with incomplete emptying
- Pressure injury protection in comatose/incontinent patient (short-term)
- Palliative care — patient comfort
NOT appropriate: Convenience catheterisation (nursing staff workload reduction), long-term use for uncomplicated UI, patient/family request alone. CAUTI risk begins at day 1.
Catheter Types & Materials
Types by Route
- Urethral catheter: short-term (TWOC/acute) or long-term (chronic urinary retention/CSU)
- Suprapubic catheter (SPC): inserted through anterior abdominal wall — more comfortable for long-term, reduced UTI risk, allows sexual activity
- Intermittent catheter: inserted to drain then removed — preferred for neurogenic bladder
Materials
- Latex: short-term only (<4 weeks), ALWAYS ask about latex allergy before insertion
- Silicone (100%): long-term (>4 weeks), latex-free, less encrustation than latex
- Hydrogel-coated: latex core coated — comfortable, absorbs water, biocompatible
- PTFE-coated: reduced friction, short-to-medium term
Catheter Sizes
- Most adults: 10–16 Fr
- Start with smallest effective size (reduces trauma/bypassing)
- 3-way catheter: 22–24 Fr (post-TURP, continuous bladder irrigation)
- Balloon sizes: 10mL (standard), 30mL (haematuria/post-TURP traction)
Female Urethral Catheterisation — Technique
1
Preparation: ANTT (Aseptic Non-Touch Technique), gather equipment (correct size catheter, sterile field, appropriate balloon syringe, drainage bag), check allergy status (latex, iodine, chlorhexidine)
2
Position: Supine frog-leg (dorsal recumbent) — knees flexed and externally rotated, heels together or feet flat. Maintain dignity throughout.
3
Cleaning: Separate labia minora with non-dominant hand (maintain throughout). Cleanse labia minora and urethral meatus in downward strokes (front-to-back), separate swab per stroke. Identify urethral meatus (located between clitoris and vaginal opening).
4
Insertion: Advance catheter 5–6cm. When urine flows, advance a further 2–3cm before inflating balloon. Never inflate balloon if resistance felt — catheter may be in urethra.
5
Balloon inflation: Inflate with correct volume sterile water (not saline — crystalises in valve). Gentle tug to confirm seated at bladder neck. Connect closed drainage system.
6
Secure & document: Secure catheter to inner thigh (prevents traction trauma). Document: date/time, catheter type/size, balloon volume, indication, patient response, urine appearance.
Common error: Catheter accidentally inserted into vagina — remove, use a new sterile catheter. A tampon or gauze in the vaginal opening helps maintain orientation on second attempt.
Male Urethral Catheterisation — Technique
1
Preparation: ANTT, position supine, penis extended vertically (90°), drape. Retract foreskin (replace afterwards — paraphimosis risk if forgotten).
2
Cleaning: Cleanse glans penis with antiseptic swabs in circular outward motion. Identify urethral meatus at apex of glans.
3
Local anaesthetic gel: Instill Instillagel (lidocaine 2% + chlorhexidine) 10–11mL into urethra. Apply gentle pressure to urethral meatus. Wait 3–5 minutes contact time for anaesthetic effect — this step is critical for patient comfort.
4
Insertion: Hold penis at 90° to abdomen to straighten urethra. Advance catheter — expect slight resistance at external sphincter (ask patient to breathe out / bear down gently). Advance to catheter bifurcation before inflating balloon.
5
Balloon inflation: Only inflate at bifurcation — ensures tip is well within bladder. If resistance to inflation — stop, reposition. If urine flow then stops on balloon inflation → catheter tip may be at bladder neck.
6
Foreskin: REPLACE foreskin after procedure. Paraphimosis (constricting band of retracted foreskin) is a urological emergency causing penile oedema and ischaemia.
Male catheterisation is a more complex skill. If resistance encountered — do NOT force. Request a more experienced clinician or urologist. False passage creation is a serious complication.
CAUTI Prevention (Evidence-Based Bundle)
Prevention Bundle
- Only catheterise when necessary — document clear clinical indication
- Daily review — remove as soon as indication resolved (each extra day = ~5% increased UTI risk)
- Closed drainage system — never disconnect unnecessarily
- Bag below bladder level — prevent backflow (do not rest on floor)
- Maintain unobstructed urine flow
- Meatal hygiene: clean with soap and water (not antiseptic)
- Hand hygiene before and after catheter manipulation
- Use smallest effective catheter size
CAUTI as GCC Quality KPI
- CAUTI rate is a reportable quality indicator in CBAHI, JCI, and HAAD standards
- Target: CAUTI rate <1 per 1,000 catheter-days
- Catheter utilisation ratio tracked in ICU and ward settings
- Root cause analysis required for each CAUTI event
- Nurse-led catheter removal protocols shown to reduce CAUTI by up to 50%
CAUTI definition (NHSN): UTI occurring in patient with urinary catheter in place for >2 days on date of event. Symptoms: fever, suprapubic tenderness, flank pain + positive urine culture ≥10³ CFU/mL.
TWOC — Trial Without Catheter
Performed after acute urinary retention, typically 48–72h after catheter insertion with treatment of underlying cause (e.g., alpha-blocker started for BPH).
1
Drain bladder fully via catheter, then optionally fill with 300–500mL warm saline (fill-to-remove protocol improves success rates)
2
Remove catheter. Patient should feel desire to void. Document time of removal.
3
Monitor void within 4–6 hours. Record volume voided. Patient should not leave until voiding confirmed.
4
Bladder scan PVR after first void. <150mL residual = TWOC success. >150mL = TWOC failure — recatheterise.
TWOC success improved by: alpha-blocker (tamsulosin) pre-treatment, catheter-free duration >24h before trial, voided volume at onset of retention <1L, younger age.
Bristol Stool Chart (BSC)
The BSC provides a validated visual scale for stool consistency — the most reproducible measure of bowel function in clinical and research settings.
1
Hard lumps
Separate hard lumps (like nuts). Constipated.
2
Lumpy sausage
Sausage-shaped but lumpy. Constipated.
3
Cracked sausage
Sausage with cracks. Borderline normal.
4
Smooth sausage
Smooth, soft. Ideal normal stool.
5
Soft blobs
Soft blobs with clear-cut edges. Borderline loose.
6
Fluffy pieces
Fluffy pieces, ragged edges. Diarrhoea.
7
Watery
Entirely liquid. Severe diarrhoea.
Types 1–2 = Constipation
Types 3–4 = Normal
Type 5 = Borderline
Types 6–7 = Diarrhoea
Constipation — Assessment & Diagnosis
Rome IV Diagnostic Criteria
Must include ≥2 of the following for at least 3 months (onset ≥6 months before diagnosis):
- ≤3 spontaneous bowel movements per week
- Straining in >25% of defaecations
- Lumpy/hard stools (BSC type 1–2) in >25% of defaecations
- Sensation of incomplete evacuation in >25%
- Sensation of anorectal obstruction in >25%
- Manual manoeuvres to facilitate >25% of defaecations
- Loose stools rarely present without laxatives
- Criteria for IBS not met
RED FLAGS — Refer Urgently
- Rectal bleeding
- Unintentional weight loss
- Change in bowel habit >6 weeks, age >50
- Iron-deficiency anaemia
- Palpable rectal/abdominal mass
Causes of Constipation
Lifestyle / Dietary
- Low dietary fibre (<25g/day)
- Inadequate fluid intake
- Physical inactivity
- Ignoring urge to defaecate
- Changes in routine/travel
Medical / Drug Causes
- Opioids — most significant drug cause
- Anticholinergics (TCAs, bladder drugs)
- Iron supplements
- Calcium-channel blockers
- Antacids (aluminium)
- Hypothyroidism
- Parkinson's disease
- Diabetes mellitus (autonomic neuropathy)
- Spinal cord injury
Constipation Management — Stepladder Approach
Step 1 — Lifestyle
- Dietary fibre: 25–35g/day (increase gradually to reduce bloating)
- Fluid: 1.5–2L/day
- Physical activity — even walking helps colonic motility
- Establish regular toileting routine (post-meals — gastrocolic reflex)
- Correct defaecation posture (footstool to elevate feet — squatting position)
Step 2 — Bulk-forming / Osmotic Laxatives
- Ispaghula husk (Fybogel): bulk-forming — must take with adequate fluid
- Macrogol (Movicol/Laxido): osmotic — first choice for most guidelines
- Lactulose: osmotic — slower onset, can cause bloating
- Magnesium salts: osmotic, faster acting
Step 3 — Stimulant Laxatives
- Senna: anthraquinone stimulant — action in 6–12h
- Bisacodyl: oral (6–12h) or suppository (20–60 min)
- Sodium picosulfate: potent stimulant
- Docusate: stool softener + mild stimulant
- Combine osmotic + stimulant for opioid-induced constipation
Opioid-Induced Constipation (OIC) — Special Consideration
Tolerance does NOT develop to opioid-induced constipation. ALL patients started on opioids MUST be prescribed a regular laxative (stimulant ± osmotic) from day one. Do not wait for symptoms.
- Methylnaltrexone (Relistor): peripherally-acting mu-receptor antagonist — does NOT cross the blood-brain barrier → reverses peripheral opioid effects on gut without reversing analgesia
- Naloxegol (Moventig): PEGylated naloxone derivative — oral, peripherally restricted
- Naldemedine: oral PAMORA, once daily
- Use PAMORAs when conventional laxatives inadequate
PAMORAs (Peripherally-Acting Mu-Opioid Receptor Antagonists): Use with caution if GI obstruction suspected. May precipitate withdrawal symptoms if opioid blood-brain barrier disrupted (e.g., brain metastases).
Faecal Impaction & Bowel Incontinence
Faecal Impaction
- Hard faeces in rectum or colon unable to be passed normally
- May present with overflow diarrhoea (liquid passes around impaction)
- Diagnosis: digital rectal examination (DRE), abdominal X-ray if high impaction suspected
- DRE: hard faecal mass palpable in rectum
Management
- Phosphate enema: stimulant/osmotic — first line for rectal impaction
- Arachis oil enema: softening — leave overnight before phosphate enema
- High-dose macrogol (Movicol 8 sachets/day × 3 days) for higher impaction
- Manual evacuation: only under protocol, adequate analgesia/sedation, DRE competency required
Bowel (Faecal) Incontinence
- Involuntary passage of faeces — significantly impacts quality of life
- Assess: history, BSC type, frequency, warning time, sphincter assessment
- Causes: diarrhoea, sphincter damage (obstetric/surgical), neurological, overflow
Management Options
- Dietary modification (soluble fibre — firming stool)
- Antidiarrhoeals: loperamide (titrate dose)
- PFMT and biofeedback (sphincter strengthening)
- Rectal irrigation (transanal irrigation)
- Sacral neuromodulation (SNS)
- ACE (Antegrade Continence Enema) procedure
- Sphincteroplasty (traumatic sphincter injury)
- Stoma (colostomy) as last resort
Diarrhoea — Assessment & Management
Definition & Assessment
- Bristol type 6–7, ≥3 loose/watery stools in 24h
- Duration: acute (<4 weeks) vs chronic (>4 weeks)
- Stool culture & sensitivity (C&S): infective causes (Salmonella, Campylobacter, C. difficile)
- C. difficile: antibiotic-associated, hospital-onset — test if >3 unformed stools/day
Common Causes
- Infective (most common — acute)
- Drug-induced (antibiotics, metformin, NSAIDs, laxative overuse)
- IBD (Crohn's/ulcerative colitis)
- Overflow (around faecal impaction)
- Coeliac disease, lactose intolerance
- Colorectal cancer (change in bowel habit)
Management Principles
- Oral rehydration therapy (ORS) — priority
- Identify and treat underlying cause
- Isolation precautions if infective
- Stop offending drugs if possible
- Stool specimen × 3 for persistent cases
- C. difficile: oral vancomycin or fidaxomicin (first-line for CDI — NOT metronidazole per IDSA 2021)
Catheter Drainage Systems
Drainage Bag Types
- Leg bag (500–750mL): worn on thigh/calf, discreet under clothing, emptied 4–6 hourly, straps must not be too tight (tourniquet effect causing oedema)
- Overnight/night bag (2L): connected to leg bag tap at night — do NOT replace leg bag, use add-on system to maintain closed drainage
- Bed/stand bag (2L): for bedbound/hospital patients, must hang below bladder, never touch floor
Catheter Valves
- Flip-flow valve: attached to catheter, patient opens every 3–4h to drain
- Maintains bladder capacity (prevents shrinkage from continuous drainage)
- Suitable for: cognitively intact patients, adequate bladder capacity, no reflux risk
- NOT suitable: detrusor hyper-reflexia, vesico-ureteric reflux, renal impairment
Changing Frequency
- Short-term urethral: up to 12 weeks (or sooner if blocked/bypassing)
- Silicone long-term: 12 weeks standard, up to 6 months if no complications
- Suprapubic: 4–12 weeks (first change by experienced clinician — track may close)
- Leg bag: change weekly
- Night bag: change daily
Catheter Problem-Solving
| Problem | Likely Cause | Action |
|---|---|---|
| Bypassing | Blockage, bladder spasm, catheter too small, constipation | Check drainage, bladder washout, antispasmodic, larger catheter, treat constipation |
| No drainage | Blockage, kinked tubing, migration, empty bladder | Straighten tubing, bladder scan, gentle flush with 10mL NS, re-site if needed |
| Encrustation | Alkaline urine (Proteus), struvite crystals | Maintain adequate hydration, Uro-tainer citric acid instillation, change catheter |
| Haematuria | UTI, trauma, clots, bladder tumour | Increase oral fluids, check for trauma, MSU, urology referral if persistent |
| Balloon won't deflate | Valve blockage, crystallisation | Introduce stylet gently, inject sterile water and aspirate, ultrasound-guided balloon puncture as last resort |
Catheter-associated UTI (CAUTI): treat only if symptomatic (fever, flank pain, rigors, new-onset confusion in elderly). Asymptomatic bacteriuria in catheterised patients does NOT require antibiotics (except pregnancy, immunosuppressed, pre-urological procedure).
Intermittent Self-Catheterisation (ISC)
Indications
- Neurogenic bladder (MS, spinal cord injury, spina bifida)
- Incomplete bladder emptying (PVR consistently >100mL)
- Urethral stricture
- Post-TWOC failure awaiting definitive treatment
- Preferred over long-term indwelling catheter — reduced CAUTI, maintained bladder capacity
Technique at Home
- Clean (not sterile) technique acceptable at home — patient's own commensal flora, no hospital pathogens
- Single-use catheters preferred for infection control
- Multi-use catheters: rinse with water, store clean and dry (max 7 days reuse per manufacturer)
- Frequency: typically 4–6 times per day (every 4–6 hours)
- Catheter volumes: aim for <400mL per catheterisation (larger volumes → overdistension → detrusor damage)
Patient & Carer Teaching
- Assess dexterity, vision, cognitive ability, motivation
- Female ISC: mirror helpful for urethral meatus identification initially
- Male ISC: straighten penis, angle change at pubic symphysis
- Hydrophilic-coated catheters: reduce trauma, lubrication not needed
- Written instructions, demonstration, return demonstration, supervised practice
- Follow-up at 1, 4, 12 weeks to troubleshoot
Catheter Selection for ISC
- Size: 10–14 Fr (smallest comfortable size)
- Hydrophilic-coated: activated with water — minimal urethral friction
- Compact/discrete catheters: social use (travel, work)
- Female catheters: shorter (6–8cm)
Continence Containment Products
Absorbent Pads
- Disposable pads: range from light (panty liner) to heavy (all-in-one/pull-up)
- Reusable washable pads: environmental and cost benefit, GCC procurement variation
- Correct size and absorbency matching to leakage volume
- Change regularly — wet pads → skin maceration, IAD (Incontinence-Associated Dermatitis)
- Skin barrier cream for perigenital skin protection
Penile Sheath (Condom Catheter)
- Non-invasive alternative for men with UI — connected to leg bag
- Sizing critical: 4cm rule — measure penile shaft circumference, correct fit prevents leakage/constriction
- Daily skin inspection: pressure marks, skin breakdown, maceration
- Change daily: clean skin, allow air dry before re-application
- Pubic hair: may need trimming to prevent adhesive failure
- Contraindicated: retracted penis, skin breakdown, priapism
Bed Protection & Other Products
- Waterproof mattress protectors (reusable/disposable)
- Absorbent bed pads (draw sheets)
- Penile clamp: short-term SUI in men — intermittent use only (<3h at a time), pressure necrosis risk
- Vaginal pessary: prolapse/SUI in women, inserted by trained clinician
- Female urethral inserts (FemSoft): for SUI, single-use urethral plug
All containment products are temporary measures. They manage symptoms but do not treat the underlying condition. Reassess continence status regularly and explore treatment options.
Digital Rectal Examination (DRE) — Nursing Competency
Indications
- Confirm faecal impaction
- Assess rectal content (BSC type)
- Assess sphincter tone (neurological assessment)
- Pre-procedure assessment (enema, suppository)
- Prostate assessment (medical staff only)
Contraindications
- Patient refusal
- Rectal/anal surgery (recent)
- Severe haemorrhoids (bleeding)
- Fissure with significant pain
- Neutropenia (ANC <0.5)
- Thrombocytopenia (platelets <50×10⁹/L)
Procedure
1
Consent: explain procedure, why needed, what to expect. Written consent for non-urgent/elective. Chaperone offered.
2
Position: left lateral with knees flexed toward chest (Sims position). Ensure privacy and dignity.
3
Inspection: examine perianal skin, haemorrhoids, fissures, prolapse, skin tags before insertion.
4
Insertion: lubricated gloved index finger, insert slowly. Assess: sphincter tone, faecal content (consistency, amount), rectal wall.
5
Document: findings, consent, patient response, action taken.
GCC-Specific Continence Practice
Cultural & Religious Context
- Incontinence widely under-reported due to cultural shame and taboo
- Healthcare professionals must routinely screen (do not wait for patient disclosure)
- Use culturally sensitive language, same-gender nurse where possible
- Family dynamics — spouse/family influence on treatment decisions
Islamic Ruling on Incontinence & Prayer
Islamic jurisprudence (fiqh) classifies urinary incontinence as a medical condition (udhr). A patient with genuine incontinence is not exempt from prayer — they are required to make wudu (ablution) for each prayer, use appropriate protection (pads), and pray. The presence of leakage during prayer due to an uncontrollable medical condition does not invalidate the prayer. Nurses should communicate this to relieve patient anxiety and encourage continence care without religious guilt.
- Catheterised patients: similar rulings — wudu performed and prayer continues
- Post-void dribble: wudu maintained if dripping stops and adequate time passes
- Consult patient's religious advisor if uncertainty — nurse role is clinical, not fatwa
Obstetric Fistula in GCC Context
Relevance
- Primarily affects women from regions with limited obstetric care (Sub-Saharan Africa, South Asia, some MENA countries)
- Significant expat workforce from these regions in GCC countries (domestic workers, labour camp workers)
- Nurses in GCC may encounter fistula in female expat patients presenting with continuous incontinence
- Often delayed presentation due to shame, language barriers, lack of access
Clinical Features
- Continuous, unremitting urinary leakage
- History of prolonged/obstructed labour, instrumental delivery, pelvic surgery or radiotherapy
- May also have rectovaginal fistula (faecal incontinence)
- Social isolation, psychological impact, skin excoriation
Refer to gynaecology/urology immediately. Surgical repair (fistuloplasty) has high success rates (80–90%) in specialist centres. Nursing role: emotional support, skin care, continence products, interpreter access.
CAUTI Prevention as GCC Hospital KPI
Accreditation Standards
- CBAHI (Saudi): CAUTI rate reported quarterly, infection prevention standard
- JCI: IPSG (International Patient Safety Goals), National Patient Safety Goals equivalent
- DHA / DOH Abu Dhabi / MOH UAE: mandatory HAI (Healthcare-Associated Infection) reporting
- HAAD: Abu Dhabi facility licensing requirements
Bundle Components
- Appropriate indication documented
- Daily review and prompt removal
- Proper insertion technique (ANTT)
- Secure and unobstructed drainage
- Perineal/meatal hygiene
- Nurse-initiated removal protocols
Reporting & Audit
- CAUTI rate = number per 1,000 catheter-days
- Catheter utilisation ratio = catheter-days / patient-days
- Monthly catheter audit by infection control nurse
- Surveillance criteria: NHSN CAUTI definition
- Mandatory RCA (root cause analysis) per facility policy
Practice MCQs — DHA / DOH / SCFHS Continence Nursing
Select your answer for each question, then click "Show Answer" to reveal the correct response with explanation.
1. A 55-year-old woman reports involuntary urine loss when she coughs and sneezes, but no urgency. Post-void residual is 30mL. Which type of urinary incontinence is MOST likely?
Correct Answer: C — Stress Urinary Incontinence. Leakage with physical effort/cough/sneeze without urgency, normal PVR, is the classic presentation of SUI due to urethral sphincter weakness/pelvic floor dysfunction. First-line treatment: PFMT for minimum 3 months.
2. You are teaching a patient about pelvic floor muscle exercises. Which instruction is MOST important to include?
Correct Answer: B. Correct PFMT technique requires squeezing and lifting upward (not bearing down — which worsens prolapse and incontinence). Stop-test (A) is only for identification, NOT regular exercise — it can cause incomplete bladder emptying and UTI. Results take ≥3 months (not 2 weeks).
3. During male urethral catheterisation, after instilling local anaesthetic gel, how long should you wait before advancing the catheter?
Correct Answer: C — 3–5 minutes. Instillagel (2% lidocaine with chlorhexidine) requires 3–5 minutes contact time to achieve adequate anaesthetic effect on the urethral mucosa. Insufficient contact time results in unnecessary pain and patient distress. This is a commonly tested clinical fact.
4. A post-surgical patient has been catheterised for 6 days. You review the catheter daily. Which action is MOST consistent with CAUTI prevention best practice?
Correct Answer: C. The single most effective CAUTI prevention measure is prompt catheter removal when the indication no longer exists. Daily review and documentation is mandated by JCI/CBAHI standards. Routine cultures (D) screen for asymptomatic bacteriuria which does NOT require treatment in catheterised patients. Breaking the closed system (B) increases infection risk.
5. A patient on regular morphine for cancer pain reports no bowel movement for 4 days. Which laxative regimen is MOST appropriate?
Correct Answer: C. Tolerance to opioid-induced constipation (OIC) does NOT develop — unlike other opioid side effects. ALL patients starting opioids must receive a regular stimulant laxative from day 1. Bulk-forming laxatives (A) are contraindicated in OIC — worsens impaction if inadequate fluid intake. If conventional laxatives fail, PAMORAs (methylnaltrexone, naloxegol) are used.
6. After a TWOC (Trial Without Catheter), the patient voids 250mL. A bladder scan shows 200mL post-void residual. What is the correct interpretation?
Correct Answer: B — TWOC failure. TWOC success criteria: voiding ≥200mL with PVR <150mL. A PVR of 200mL significantly exceeds the 150mL threshold. The patient requires re-catheterisation and urology/continence review. A PVR/voided volume ratio >33% is also a failure indicator.
7. Which medication for OAB has the LEAST anticholinergic side effects and is preferred in elderly patients?
Correct Answer: C — Mirabegron. Mirabegron is a beta-3 adrenoceptor agonist with a completely different mechanism from anticholinergics — it relaxes the detrusor without muscarinic side effects (dry mouth, constipation, cognitive impairment). Oxybutynin IR (A) has the highest CNS anticholinergic effects and is on the BEERS criteria for drugs to avoid in older adults. Mirabegron requires BP monitoring.
8. A patient with a long-term silicone indwelling catheter reports the catheter is leaking around it (bypassing). The catheter is not blocked. What is the MOST likely cause?
Correct Answer: C — Bladder spasm. When the catheter is patent (not blocked) and urine bypasses around it, bladder spasm/detrusor overactivity is the most common cause — the bladder contracts forcefully around the catheter. Management: antispasmodic (oxybutynin/solifenacin), adequate hydration, manage constipation. Using a larger catheter (A) worsens spasm by increasing urethral/trigone irritation.
9. When performing intermittent self-catheterisation (ISC) at home, which technique is recommended?
Correct Answer: B — Clean technique. At home, ISC uses clean (not sterile) technique — the patient is exposed to their own commensal organisms, not hospital-acquired pathogens. Thorough handwashing and clean (not necessarily sterile) catheter handling is adequate and practical. Routine antibiotic prophylaxis (D) is NOT recommended — promotes resistance. Sterile technique (A) is used in hospital settings.
10. A 3-day bladder diary shows a patient voids 14 times in 24 hours with average volumes of 85mL. Post-void residual is 25mL. What is the MOST appropriate initial management?
Correct Answer: B — Bladder training. Voiding 14 times/day with small volumes (85mL) indicates OAB with reduced functional bladder capacity. Normal frequency is 4–8 voids/day. First-line: bladder training (urgency suppression, gradually extending intervals) + fluid/caffeine review. Conservative therapy must precede pharmacology. Fluid restriction (D) worsens concentrated urine irritation. Catheterisation (C) is completely inappropriate.
Bladder Diary Analyser
Enter your patient's 3-day average values to generate a clinical assessment, incontinence type prediction, and management pathway recommendation.